Allergan’s Skinvive Gets FDA Approval for Additional Use - Orange County Business Journal

FDA Clears New Injectable Option for Horizontal Neck Lines

Clinical trial results showed improvements in neck appearance lasting up to six months following treatment. Allergan Aesthetics, an AbbVie company, announced the US Food and Drug Administration (FDA) approval of Skinvive by Juvederm to reduce neck lines for the improvement of neck appearance in adults over the age of 21.  Neck wrinkles may develop due to natural aging, sun damage, weight loss, or “tech-neck” caused by the head-down position used…

Allergan’s Skinvive Gets FDA Approval for Additional Use - Orange County Business Journal

Allergan Aesthetics, the Irvine-based aesthetics unit of Chicago biopharmaceutical giant AbbVie Inc., today announced FDA approval of Skinvive to reduce neck lines for the improvement of neck appearance. With the approval, Skinvive is now the first and only hyaluronic acid injectable approved to reduce horizontal neck lines caused by prolonged periods of looking down at phones, tablets or laptops, known as “tech neck,” according to Allergan. “Th…